论文部分内容阅读
目的 :探讨用丹参酮ⅡA璜酸钠注射液治疗脑梗死的临床效果。方法 :对2012年3月~2014年3月期间我院收治的68例脑梗死患者的临床资料进行回顾性研究。我们将这68例患者随机分为对照组与观察组,每组各有34例患者。我院采用西医常规疗法对对照组的患者进行治疗,在此基础上,用丹参酮IIA磺酸钠注射液对观察组的患者进行治疗。治疗结束后,观察并比较两组患者的临床疗效。结果 :观察组患者治疗的总有效率明显高于对照组的患者,其脑血流相关指标的改善情况明显优于对照组的患者,二者相比差异有显著性(P<0.05)。结论 :用丹参酮ⅡA璜酸钠注射液对脑梗死患者进行治疗可以快速地改善其脑血流的情况,提高其临床疗效,并改善其远期预后。该疗法值得在临床上推广使用。
Objective: To investigate the clinical effect of tanshinone ⅡA sodium sulfonate injection on cerebral infarction. Methods: The clinical data of 68 patients with cerebral infarction admitted from March 2012 to March 2014 in our hospital were retrospectively studied. We randomly divided the 68 patients into control and observation groups, each with 34 patients in each group. In our hospital, the patients in the control group were treated by conventional western medicine. On the basis of this, the patients in the observation group were treated with sodium tanshinone IIA sulfonate injection. After treatment, observe and compare the clinical efficacy of two groups of patients. Results: The total effective rate of observation group was significantly higher than that of the control group, and the improvement of cerebral blood flow related index was better than that of the control group. There was significant difference between the two groups (P <0.05). Conclusion: The treatment of patients with cerebral infarction with tanshinone Ⅱ A sodium sulfonate injection can rapidly improve the cerebral blood flow, improve its clinical efficacy and improve its long-term prognosis. The therapy is worth promoting in clinic.